PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.06 and traded as high as $0.07. PURE Bioscience shares last traded at $0.0645, with a volume of 25,742 shares changing hands.
PURE Bioscience Stock Performance
The company has a 50-day moving average of $0.07 and a 200-day moving average of $0.06. The stock has a market cap of $8.39 million, a price-to-earnings ratio of -2.15 and a beta of 0.11.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its quarterly earnings data on Monday, March 16th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.44 million for the quarter.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Further Reading
- Five stocks we like better than PURE Bioscience
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
